ASX Share rice
Wed 12 Aug 2020 - 10:50:am (Sydney)

ALT Share Price

ANALYTICA LIMITEDALTHealth Care Equipment & Services

ALT Company Information

Name:

Analytica Limited

Sector:

Healthcare

Industry:

Medical Appliances & Equipment

GIC Industry:

Health Care Equipment & Supplies

GIC Sub Industry:

Health Care Equipment

Address:

320 Adelaide Street Brisbane QLD Australia 4000

Phone:

61 7 3278 1950

Exec. Chairman:

Dr. Michael Monsour

Chief Exec. Officer:

Mr. Geoff Daly BE (Hons, Mech, UQ), MBA (Exec, AGSM), MIEAust CPE

CFO & Exec. Director:

Mr. Ross Mangelsdorf B.Bus, FCA, CTA, FTIA, MAICD

Product Devel. & Operations Mang.:

Ms. Chelsea Cornelius

VP of Global Marketing:

Ms. Megan Henken

Company Overview:

Analytica Limited designs, develops, and supplies medical devices in Australia, the United Kingdom, and the United States. The company's lead product is PeriCoach system, an e-health treatment system for women who suffer stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Analytica Autostart Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited is based in Brisbane, Australia.

ALT Share Price Information

Shares Issued:

3.52B

Market Capitalisation:

$8.80M

Revenue (TTM):

$1.52M

Earnings per Share:

$-0.001

Profit Margin:

-0.6477

Operating Margin (TTM):

$-0.64

Return On Assets (TTM):

$-0.35

Return On Equity (TTM):

$-0.76

Quarterly Revenue Growth (YOY):

33.231

Gross Profit(TTM):

$-895,250

ALT CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-52,266

Change To Liabilities:

$95.76K

Total Cashflow From Investing Activities:

$-52,266

Net Income:

$-2,054,174

Total Cash From Operating Activities:

$-1,880,724

Depreciation:

$10.85K

Change To Inventory:

$20.22K

Change To Account Receivables:

$-1,951

Sale Purchase Of Stock:

$-51,868

Capital Expenditures:

$52.27K

ALT Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-2,054,174

Net Income:

$-2,054,174

Gross Profit:

$37.62K

Operating Income:

$-2,785,813

Interest Expense:

$2.78K

Total Revenue:

$54.81K

Total Operating Expenses:

$2.82M

Cost Of Revenue:

$17.19K

ALT Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$235.22K

Total Liabilities:

$571.49K

Total Stockholder Equity:

$1.67M

Other Current Liabilities:

$40.70K

Total Assets:

$2.24M

Common Stock:

$103.87M

Retained Earnings:

$-103,132,370

Other Liabilities:

$9.40K

Cash:

$1.77M

Total Current Liabilities:

$562.10K

Property - Plant & Equipment:

$12.26K

Net Tangible Assets:

$1.43M

Long-Term Investments:

$15.67K

Total Current Assets:

$1.98M

Net Receivables:

$21.54K

Short-Term Investments:

$263.15K

Inventory:

$118.11K

Accounts Payable:

$248.04K

Non Currrent Assets (Other):

$263.15K

Short-Term Investments:

$263.15

Non Current Liabilities Total:

$9.40K

ALT Share Price History

ALT News

25 Apr, 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
27 Jan, 2020
Analytica Limited (ASX:ALT) shareholders should be happy to see the share price up 17% in the last week. But will that...
17 Jan, 2020
Cambridge Analytica whistleblower Brittany Kaiser has released new documents today that illuminate the initial jockeying between the company and Facebook as they discussed the need for Cambridge Analytica to delete data associated with 87 million Facebook users' profiles. The data was improperly obtained in 2014 by researchers with access to Facebook's developer platform who were being paid by Cambridge Analytica to obtain and process social media users' information for the purpose of targeting political ads. In December 2015 a Guardian article about Cambridge academic Dr Aleksandr Spectre (Kogan) outlined how he had acquired the Facebook profiles for research, and that Cambridge Analytica had improperly acquired that data.
06 Jan, 2020
More details are emerging about the scale and scope of disgraced data company Cambridge Analytica's activities in elections around the world -- via a cache of internal documents that's being released by former employee and self-styled whistleblower, Brittany Kaiser. The now shut down data modelling company, which infamously used stolen Facebook data to target voters for President Donald Trump’s campaign in the 2016 U.S. election, was at the center of the data misuse scandal that, in 2018, wiped billions off Facebook's share price and contributed to a $5BN FTC fine for the tech giant last summer.
03 Dec, 2019
Geoff Daly has been the CEO of Analytica Limited (ASX:ALT) since 2014. First, this article will compare CEO...
20 Oct, 2019
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
19 Sep, 2019
Analytica Limited (ASX:ALT) continues its loss-making streak, announcing negative earnings for its latest financial...
20 Aug, 2019
Some stocks are best avoided. We really hate to see fellow investors lose their hard-earned money. Anyone who held...